Zantac
Product Images NDC 52565-102

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zantac (NDC 52565-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teligent Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Molecular Structure)

Chemical structure diagram of the active ingredient in ZANTAC. The diagram shows molecular bonds and groups characteristic of the compound, including amine, nitro, and heterocyclic elements, clearly labeled with chemical groups and bonds.*

FDA Label Image

Zantac 2ml Pdp

Zantac (ranitidine) Injection label showing strength of 50 mg/2 mL (25 mg/mL) in a 2 mL single dose vial. The label indicates sterile, Rx only, for IV, IM, or IV use, containing 0.5% phenol as a preservative. Manufactured by Teligent Pharma, Inc.*

FDA Label Image

Zantac 6ml Pdp

ZANTAC (ranitidine) Injection 150 mg/6 mL (25 mg/mL) multiple dose vial label. The sterile, Rx-only injectable solution is labeled for intravenous or intramuscular injection or infusion. The label includes usage, storage instructions, and regulatory information. Manufactured by Teligent Pharma, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.